Here two murine salivary gland cancer (SGC) cell lines WR21 and SCA-9 were studied for the first time in detail by high-resolution molecular cytogenetic approaches. This study revealed that these cell lines are models for human SGCs of initial stage myoepithelioid or mucoepidermoid (WR21) and of advanced stage mucoepidermoid (SCA-9) tumors. Besides, three genes most likely playing a role in SGC development (FGF10, ELAVL1/HUR and SEL1) were identified. All of them were involved in translocation events in these in vitro models and thus were most likely activated. Overall, the present study highlights the necessity not only to establish but also to genetically characterize murine tumor cell lines. Without such a characterization they cannot be used in a reasonable way in research.
Introduction
Salivary gland cancers (SGCs) are a specific and rare subgroup of tumors known from oral and maxillofacial clinical practice. They account for around 3-5 % of all head and neck cancers and for only less than 0.5 % of all cancers (Zboray et al., 2018) . Nevertheless, SGCs include more than 35 histological subtypes and are known for their progressive and heterogeneous clinical behavior (El-Naggar et al., 1997; Persson et al., 2009; Cao et al., 2018) .
The mentioned subtypes of SGCs exist partially due to the fact that salivary glands consist of three major paired glands (parotid, submandibular and sublingual) and minor glands, located in the mucosa of the palate, lips and respiratory tract (Omitola and Iyogun, 2018; Zboray et al., 2018) . Tumors located in the parotid part are only 25 % malignant. However, the incidence of malignancies is much higher in the submandibular part (50 %) and minor salivary glands (60-80 %) (Sood et al., 2016; Solanki, 2011) . In general, SGCs are divided in two forms: (i) a simple palpable lump, being well-defined, discrete, and mobile, and (ii) a lump with significant accompanying symptoms like pain, rapid growth, fixity to surrounding structures, nerve involvement and/or neck metastasis (Sood et al., 2016) . Current therapeutic options for human SGCs are limited. Depending on their location, some SGCs can be surgically addressed, while others are difficult to remove completely. Radiation therapy is used; still it has turned out to be less effective for clinical treatment. Accordingly, chemotherapy is the only treatment option in metastatic SGCs (Keller et al., 2017; Zboray et al., 2018) .
The detailed molecular mechanisms controlling tumor progression and metastasis in SGCs and their genetic profiles are still not well understood (Vekony et al., 2009 ). However, characterization of these underlying mechanisms is essential for understanding and development of more effective methods of diagnosis and treatment against the disease (Murase et al., 2016) . Hence, there is a need for better understanding of the genetics and molecular mechanisms of SGC-pathogenesis, to be used in the future toward the development of novel therapeutic approaches (Cao et al., 2018; Murase et al., 2016; Zboray et al., 2018) .
One possible approach for studying the biology of SGCs and developing new therapeutic strategies is the use of mouse models (Zboray et al., 2018) . Previous research showed that submandibular gland-derived tumor cell lines present characteristics of differentiated epithelial cells and can be used to study proliferation signaling pathways and their regulation (Trzaskawka et al., 2000; Español et al., 2012) . Still, surprisingly, murine cell lines used as models for human SGCs have not yet been very well characterized genetically for their tumor-associated alterations.
Fluorescence in situ hybridization (FISH) and microarray-based comparative genomic hybridization (array CGH) were used in this study to determine the genomic aberrations of the two murine SGC cell lines WR21 and SCA-9. WR21 was first described by Young et al. (2006) as being derived from a salivary tumor in a male wap-ras subline 69-2 (C57BL/6, SJL) transgenic mouse; it was already established in 1989. Such tumors are described as extremely aggressive and as expressing high levels of oncogenic ras-protein from the activated human H-RAS transgene (Nielsen et al., 1994) . SCA-9 was already established in 1980 (Barka, 1980; Barka et al., 2005) and was derived from a carcinogen (7,12-dimethylbenz(a)anthracene) -induced tumor of a male Swiss-Webster mouse submandibular gland. Both cell lines have only been applied in 10 published studies (see Pubmed: https://www.ncbi.nlm.nih.gov/ pubmed/?term=wr21 and https://www.ncbi.nlm.nih. gov/pubmed/?term=SCA-9+mouse), which may also be due to the fact that their genetics had not been studied in detail. Here, we analyzed WR21 and SCA-9 cell lines by FISH-banding and aCGH and aligned them with their human SGC subtypes.
Material and Methods

CELL LINES
The cell lines WR21 and SCA-9 were obtained from American Type Culture Collection (ATCC® CRL-2189™, ATCC® CRL-1734™; Middlesex, UK). They are indicated there as 'not further characterized salivary tumor lines' to be grown adherently in DMEM medium containing 10 % fetal calf serum in the presence of antibiotics. For this study, cells were worked up cytogenetically as previously reported (Rhode et al., 2018) and in parallel whole genomic DNA was extracted using the Blood & Cell Culture DNA Midi Kit (Qiagen; Hilden, Germany) according to the manufacturer's instructions and described elsewhere (Kubikova et al., 2017) . We conducted molecular cytogenetic analyses on the cell line-derived chromosomes and aCGH analyses on the extracted DNA (see below).
According to the ethical committee (medical faculty) and the Animal Experimentation Commission of the Friedrich Schiller University, there are no ethical agreements necessary for studies involving murine tumor cell lines like WR21 and SCA-9.
MOLECULAR CYTOGENETICS
FISH was performed as previously described (Kubikova et al., 2017) . Whole chromosome paints ("SkyPaint TM DNA Kit M-10 for Mouse Chromosomes", Applied Spectral Imaging, Edingen-Neckarhausen, Germany) were used for multicolor-FISH (mFISH), and murine chromosome-specific multicolor banding (mcb) probe mixes for FISH-banding (Liehr et al., 2006) . At least 30 metaphases were documented and analyzed for each probe set ((including using SkyPaint TM ) Zeiss Axioplan microscopy, equipped with ISIS software (MetaSystems, Altlussheim, Germany)). Array-based comparative genomic hybridization (aCGH) was done according to standard procedures by "SurePrint G3 Mouse CGH Microarray, 4×180K" (Agilent Technologies) (Kubikova et al., 2017) .
DATA ANALYSIS
The breakpoints and imbalances of WR21 and SCA-9 were determined after analyses of aCGH and mcb data, and aligned to human homologous regions using Ensembl and the UCSC Genome Browser, as previously described (Leibiger et al., 2013) . The obtained data were compared to genetic changes known from human SGCs according to Fowler et al. (2006) , Rao et al. (2008) , Persson et al. (2009 ), Vekony et al. (2009 , Jee et al. (2013) and Matse et al. (2017) .
Results
WR21 is mitotically relatively stable, and the neardiploid karyotype has an overall low rate of single cell aberrations; still, it developed two main clones. Clone 1 represents 16.6 % of the cells and has the karyotype 44,XY,+Y,+inv(4)(A1C4),+8,der(9)(A1->E2::E1-qter),der(12)(A1->F2::F1->qter),+19. Clone 2 together with one subclone was found in 83.4 % of the cells. Main- clone of clone 2 revealed the karyotype 43,XY,+Y,inv(4) (A1C4),+der(4)t(4;8)(:4C4->4A4::A1-E2),+19 and was present in 77 % of all cells (Fig. 1) . In the remaining 6.4 % of the cells, clone 2 further acquired a loss in one of the Y-chromosomes; i.e., there was a del(Y) -this subset was called clone 2a.
In SCA-9 most chromosomes are tetraploid and the cell line is chromosomally instable, as reflected by many single cell aberrations: 62~76,XX,-1,-2,idic(4)(A1;A1),del(4) (C1),del(4)(C1),der(5)(A1->G3::G3->G2:),der(5)t(5;8) (5A1->5G3::5G3->5G2::8B1->8E2),+6,-7,-8,-8,-9,-12,-12,-13,der(14)t(14;8)(C1;A1)x2, der(18)t(18;12)(D;E),-18 
CYTOGENETICS
Most data from the mFISH and mcb for the WR21 and SCA-9 (Table 1) agreed with the aCGH data; the results are shown in Figs. 3 and 4 . Some small deletions in murine chromosome 2 and gains in murine chromosomes 3 and 4 (here 4A4 to 4C4, clearly visible mcb) were missed in aCGH. These results were translated to the human genome in the same figures. For this study, imbalances larger than 3.5 megabase pairs were included in the evaluation.
According to the corresponding homologous regions in the human karyotype, we compared the results for both cell lines (Table 1 and 2) with the imbalances for four (adenoid cystic carcinoma, myoepitheliomas, pleomorphic adenoma and mucoepidermoid) of the most common types of SGCs. The highest concordance was found with SGCs of myoepitheliomas and mucoepidermoid for WR21, and of mucoepidermoid for SCA-9. 
Discussion
Both the low incidence and heterogeneity of pathology in SGCs explain why this tumor is one of the least studied human cancer types (Seethala, 2017) . SGCs present a diverse range of histological and clinical characteristics (Sood et al., 2018) . In the literature, there is also significant heterogeneity in the aberrant genetic and molecular pathways described contributing to the development of SGCs (Müller, 2013; Yin and Ha, 2016 ).
The two murine tumor cell lines which we examined, commercially available as model systems for SGCs, were successfully studied using molecular cytogenetics (mFISH, mcb and aCGH) to provide a comprehensive cytogenetic description regarding ploidy, numerical and structural aberrations and tumor-associated breakpoints, as previously done for other murine tumor cell lines (Leibiger et al., 2013; Kubicova et al., 2017; Guja et al., 2017; Rhode et al., 2018) .
In our results, clonal changes with few aberrations from the main clone were observed in both cell lines, 
CYTOGENETICS
even though two small subclones (denominated as 1 and 2a) were characterizable in WR21 besides one mainline (clone 2). As these cell lines were not karyotyped at the time of establishing, nothing can be stated about karyotypic evolution since then. Considering our own previous studies in other, several decades-old cell lines with known original chromosomal content (Leibiger et al., 2013; Kubicova et al., 2017; Guja et al., 2017; Rhode et al., 2018) , all of those were surprisingly stable compared to the original description of the chromosome sets.
Overall, WR21 showed clearly a less aberrant karyotype than SCA-9. Compared to most other solid epithelial tumors, SGCs often were correlated with a normal karyotype or small numbers of chromosomal aberrations (Martins et al., 1995; El Naggar et al., 1997; Hungermann et al., 2002; Vekony et al., 2009) , and as expected, salvia carcinomas displayed more chromosomal events than benign tumors from this tissue (Vekony et al., 2009 ). Thus, WR21 may represent a benign or less advanced cell line than SCA-9. This view is also supported by the fact that polyploidization, i.e. a basic tetraploid karyotype, was observed only in SCA-9, while WR21 was diploid with a gain of only three (derivative) chromosomes. This could be related to telomere-driven tetraploidization in the context of tumor progression (Davoli and de Lange, 2012) , but could also be just a cell culture effect (Mastromonaco et al., 2006) .
Gains of copy number were observed in both studied cell lines; while gains were more frequent than loss for WR21, the data interpretation used for SCA-9 seems to show a loss rather than a gain of copy numbers. However, this is due to the fact that SCA-9 was interpreted as basically tetraploid -so the high frequency of losses as given in Fig. 4 must consider that this cell line has a massive gain of copy numbers along the entire genome, and the summary in Fig. 4 rather highlights the genomic instability of this cell line.
According to the characterization of WR21 and SCA-9, neither cell line is a model for adenoid cystic carcinomas or pleomorphic adenomas, but most likely for mucoepidermoid SGCs (SCA-9, WR21) and/or myoepitheliomas (WR21 -see Tabs. 1-2).
Interestingly, the breakpoint 13D2 observed in WR21 comprises the gene FGF10 (see suppl. Tab. 1), which has been associated with salivary gland development (Krejci et al., 2009 ) and breast cancer (Itoh and Ohta, 2014) . Maybe this is a hint that this gene also plays a role in SGCs. For SCA-9 similarly a breakpoint in 8A1 could be associated with the gene ELAVL1, also called HUR, being described as playing a role in salvia metabolism (Palanisamy et al., 2008) and mucoepidermoid SGC (Cho et al., 2007) . The latter confirms that SCA-9 is a model for advanced mucoepidermoid SGC. Another breakpoint (12E) including gene SEL1 plays a role in the salivary glands of Sjögren's syndrome patients (Barrera et al., 2016 ).
In conclusion, the present study narrowed down the subtypes of two long established murine cancer cell lines to SGCs of mucoepidermoid (SCA-9, WR21) and/ or myoepithelioma (WR21) subtypes and identified three oncogenes potentially playing a role in SGC development. FGF10, ELAVL1/HUR and SEL1 should be further studied with special attention in SGCs. The chromosomal content of the cells should certainly be controlled before doing extensive further studies, to exclude studying subclones with potentially different and/ or advanced karyotypic evolution. 
